loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Certificates of Suitability (CEPs) for r1_cep_1998_119___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 GlaxoSmithKline Group of Companies Greenford GB (1)

filter

01 Labetalol Hydrochloride (1)

filter

01 United Kingdom (1)

filter

01 Withdrawn by Holder (1)

URL Supplier Web Content
R1-CEP 1998-119 - Rev 01
Withdrawn by Holder
Chemical
2008-07-16
2013-04-22
923
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R1-CEP 1998-119 - Rev 01 of Glaxosmithkline Group Of Companies Greenford Gb

Looking for Certificates of Suitability (CEPs) for R1-CEP 1998-119 - Rev 01 of Glaxosmithkline Group Of Companies Greenford Gb 1

20

Glaxosmithkline Group Of Companies Greenford Gb, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their significant offerings is Labetalol Hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-119 - Rev 01

This Chemical Type CEP, issued on July 16, 2008, remains in force until April 22, 2013, ensuring its reliability within the pharmaceutical industry.

Substance Number 923 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY